Vanguard Capital Management LLC Acquires 5.04% Stake in Jazz Pharmaceuticals PLC

Vanguard Capital Management LLC has filed a Schedule 13G with the SEC, reporting a new 5.04% stake in Jazz Pharmaceuticals PLC. As of the event date on March 31, 2026, Vanguard beneficially owns 3,103,522 shares of common stock. The filing indicates that Vanguard holds sole dispositive power over the entire position of 3,103,522 shares, while maintaining sole voting power over 455,189 shares. This position was acquired in the ordinary course of business and is not intended to influence or change the control of the issuer. The reporting entity includes various affiliates such as Vanguard Asset Management Limited and Vanguard Global Advisers, LLC. This filing marks a significant increase from a previous ownership level of 0%, crossing the 5% regulatory threshold that requires public disclosure. The total value of the holding is estimated at approximately $629.14 million based on the provided financial data.